SNOA Stock Catalyst: Sonoma Pharmaceuticals Receives U.K. Regulatory Clearances for Wound Care and Dermatology Products

Mar 10, 2025 · 9:35am ET

The clearances were granted by the Medicines and Healthcare products Regulatory Agency (MHRA).

Max move

+102.1%

High of day $4.75

Sparker timei

9:35am ET

SNOA · Mar 10, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Sonoma Pharmaceuticals, Inc. (SNOA) has received extensive regulatory clearances in the United Kingdom for its key wound care and dermatology products. The clearances were granted by the Medicines and Healthcare products Regulatory Agency (MHRA).

The clearances cover multiple products within Sonoma's wound care and dermatology portfolios, enabling the company to expand its market presence in the U.K.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time SNOA sparks.

Download Sniper App →

Catch the next SNOA-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →